Amanda Colman
Primary Care · Titusville, FLNPI 1336796549
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Johnson & Johnson at 26.3% of the total. Reporting peaked in 2023 at $1,576 and has fallen 91.0% since, to $142 in 2025. Among primary care clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $25.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Cvrx, Inc.$611
- Merck$566
- Amgen$392
- Novartis$340
- Boehringer Ingelheim$259
- plus $1K from 20 others
What the payments were for
- Food & beverage$4,50996%
- Education$1674%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 40 | $1,228 |
| Cvrx, Inc. | 19 | $611 |
| Merck | 27 | $566 |
| Amgen | 15 | $392 |
| Novartis | 18 | $340 |
| Boehringer Ingelheim | 13 | $259 |
| Astellas Pharma US Inc | 3 | $167 |
| Pfizer | 8 | $155 |
| Abiomed | 4 | $143 |
| E.r. Squibb & Sons, L.L.C. | 8 | $118 |
| Esperion Therapeutics, Inc. | 5 | $108 |
| Biosense Webster, Inc. | 1 | $107 |
| AstraZeneca | 5 | $81 |
| Sanofi-aventis U.S. LLC | 4 | $77 |
| Novo Nordisk | 5 | $68 |
| Edwards Lifesciences | 1 | $49 |
| Lexicon Pharmaceuticals, Inc. | 2 | $35 |
| GE HealthCare | 1 | $24 |
| Boston Scientific | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $22 |
| Bayer | 1 | $22 |
| Impulse Dynamics (USA) Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Medline Industries LP | 1 | $14 |
| Atricure, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$248
- XARELTO$248
- VERQUVO$220
- SPRAVATO$125
- Carto 3$107
How this compares
$4,676 in reported general payments places this provider in the 90th percentile of 725 primary care providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 11 | $123 |
Paid to pharmacies, not to this prescriber.
Other primary care in Titusville
- Paul ChanOrlando$447K
- Jenny WestPensacola$80K
- Railet RodriguezAltamonte Springs$14K
- Kevin HanawayFort Lauderdale$12K
- Kelly ChewningAlachua$11K
- Yolanda PalmeroSaint Cloud$11K
- Erica ClarkCitrus Springs$11K
- Michelle SelvaggiLakewood Ranch$10K
- Kristen DeasonTallahassee$10K
- Robert PerriPalm Coast$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.